Navigation Links
Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results
Date:6/11/2009

N STATEMENTS OF OPERATIONS (Unaudited) Three months ended March 31, Year ended March 31, 2009 2008 2009 2008 Revenue: Product revenue $2,557,655 $3,136,577 $14,528,916 $18,587,376 Royalty and other revenue 2,036,100 164,200 14,832,605 708,905 Total revenue 4,593,755 3,300,777 29,361,521 19,296,281 Operating expenses: Cost of product revenue 1,341,874 1,303,054 5,685,577 6,160,245 Cost of royalty and other revenue 269,745 - 1,091,297 - Research and development 4,644,799 2,357,696 12,771,573 7,240,812 Selling, general and administrative 1,552,871 3,504,362 5,933,090 10,173,400 Net gain from litigation settlement - - - (40,170,000) Total operating expenses 7,809,289 7,165,112 25,481,537 (16,595,543) Income (loss) from operations (3,215,534) (3,864,335) 3,879,984 35,891,824 Investment income 374,816 668,480 1,895,706 2,051,258 Interest expense (676) (1,744) (2,963) (9,097) Income (loss) before income taxes (2,841,394) (3,197,599) 5,772,727 37,933,985 Income tax (benefit) provision (148,156) - 26,699 827,471 Net income (loss) $(2,693,238) $(3,197,599) $5,746,028 $37,106,514 Earnings (loss) per share: Basic $(0.09) $(0.10) $0.19 $1.20 Diluted $(0.09) $(0.10) $0.18 $1.18 Weighted average shares outstanding: Basic 30,697,818 31,064,4
'/>"/>
SOURCE Repligen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2009 Results
2. Repligen to Present at the Cowen and Company 29th Annual Healthcare Conference Monday, March 16th, 2:25 p.m. EDT
3. Repligen Reports Third Quarter Fiscal Year 2009 Financial Results
4. Repligen to Present at the BIO CEO & Investor Conference Monday, February 9th, 11:30 a.m. EST
5. Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results
6. Repligen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference Monday, November 10th, 4:55 p.m. EST
7. Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT
8. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
9. Repligen Receives Research Grants to Support Friedreichs Ataxia Development Program
10. Repligen Announces Conference Call of First Quarter Fiscal Year 2009 Results
11. Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Medical Systems (NYSE: VAR ), world leader in ... to sustainability with inclusion on a prestigious list of the ... equipment company among the Corporate Knights Global 100 Most Sustainable ... Davos, Switzerland . "We ...
(Date:12/24/2014)... 2014  United Therapeutics Corporation (NASDAQ: UTHR ) ... ) has submitted a pre-market approval application to the ... of Medtronic,s SynchroMed ® II implantable drug infusion ... United Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously ...
(Date:12/24/2014)... December 23, 2014 “Preparative & ... HPLC, Flash), Consumables (Columns, Solvents, Buffers, Valves, Guages, ... & Agriculture) - Forecasts to 2019” provides a ... opportunities, current market trends, and strategies impacting the ...
(Date:12/24/2014)... MD (PRWEB) December 23, 2014 On ... H.R. 83, the Omnibus and Continuing Resolution Appropriations Act ... a condition eligible to receive funding through the Congressionally ... of Defense (DoD). The Hydrocephalus Association (HA), working in ...
Breaking Biology Technology:Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2
... Ardea Biosciences, Inc. (Nasdaq: RDEA ) announced ... officer, will present at the Oppenheimer 21st Annual Healthcare Conference ... at 10:50 a.m. EDT on Tuesday, November 2, 2010. ... accessed on the Investor Relations section of Ardea,s website at ...
... lot of waste products, but one of these, eggshells, could ... International Journal of Global Warming this month. ... demonstrated that the membrane that lines an eggshell can absorb ... carbon dioxide from the atmosphere. The carbon dioxide thus trapped ...
... 26 BioMed Realty Trust, Inc. (NYSE: ... announced acquisition of the Science Center at Oyster Point ... campuses in the South San Francisco life science market, ... of laboratory, office and industrial space. The properties were ...
Cached Biology Technology:Ardea Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference 2Scrambling for climate change solutions 2BioMed Realty Trust Completes South San Francisco Portfolio Acquisition 2BioMed Realty Trust Completes South San Francisco Portfolio Acquisition 3BioMed Realty Trust Completes South San Francisco Portfolio Acquisition 4
(Date:12/17/2014)... The Defense Logistics Agency is insourcing its efforts ... microcircuits from entering into its supply chain. ... initiative dubbed DNA marking. The capability will validate the ... the supply chain. The new quality control measures will ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... "Global Facial Recognition Market 2015-2019" report to ... Facial recognition is a technology used for ... overall facial feature of a person such as nose, ...
(Date:12/10/2014)... , Dec. 8, 2014 You,ve been here before: you desperately ... your password, site key or the answer to your secret question. ... Today, Hoyos Labs , a digital infrastructure security ... end to the frustration that comes with usernames, passwords and PINs ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and ... revealed new insights into how sex chromosomes are regulated. ... that males have only one copy of the sex ... between male and female sex chromosomes in fruit flies ...
... have come together to announce funding for new projects ... in the emerging field of synthetic biology. The Biotechnology ... and Physical Sciences Research Council (EPSRC) have awarded funding ... UK researchers to build links across institutions and discipline ...
... fruit fly circling your week-old peach has helped scientists ... eggshell formation. The paradoxical finding gives scientists a ... forms as it points to a likely target for ... the Medical College of Georgia Schools of Medicine and ...
Cached Biology News:X chromosome exposed 2New projects to raise UK profile in synthetic biology 2Fruit fly helps identify protein critical to eggshell formation that may be pesticide target 2Fruit fly helps identify protein critical to eggshell formation that may be pesticide target 3
Bovine Serum Albumin Peroxidase Stabilizer Solution, 1 L...
SAIVI Alexa Fluor 680 injectable contrast agent *bovine serum albumin*...
... Lysate contains the cellular components necessary for ... elongation and termination factors) but has not ... is used primarily for the isolation of ... of endogenous globin mRNA. Untreated Lysate is ...
RAT ANTI MOUSE METALLOPHILIC MACROPHAGES...
Biology Products: